IsoRay, Inc. States Its Policy Not to Comment on Unusual Market Activity - KOTA Territory News

IsoRay, Inc. States Its Policy Not to Comment on Unusual Market Activity

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE IsoRay, Inc.

RICHLAND, Wash., Feb. 27, 2013 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR) ("IsoRay" or the "Company"), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, released the following statement today.

In view of the unusual market activity in IsoRay's common stock on February 26 and 27, 2013, the New York Stock Exchange has contacted the Company in accordance with its usual practice. IsoRay stated that its policy is not to comment on unusual market activity.

About IsoRay
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body.  Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Join us on http://www.facebook.com/#/Isoray.   Follow us on https://twitter.com/#!/Isoray.

Contact:
Worldwide Financial
(954) 360-9998
info@wwfinancial.com

©2012 PR Newswire. All Rights Reserved.